EMA Alerts Stakeholders To Next Steps For EU Drug Safety Monitoring System
Executive Summary
The European Medicines Agency has outlined key steps it plans to take over the next couple of years to improve the EudraVigilance drug safety monitoring system, including easier access for organizations and users, better communications with stakeholders, and the introduction of new reporting formats. Predictably, there's a Brexit sting in the tail.
You may also be interested in...
Enhanced EudraVigilance System Goes Live, EMA Updates Info For Users
After months of preparations, the European Medicines Agency’s improved pharmacovigilance database has gone live on schedule.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.